K. Willey

440 total citations
10 papers, 331 citations indexed

About

K. Willey is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Nephrology. According to data from OpenAlex, K. Willey has authored 10 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Pharmacology and 3 papers in Nephrology. Recurrent topics in K. Willey's work include Pharmacology and Obesity Treatment (4 papers), Diabetes Treatment and Management (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). K. Willey is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), Diabetes Treatment and Management (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). K. Willey collaborates with scholars based in Australia, United States and Germany. K. Willey's co-authors include Maria A. Fiatarone Singh, Lynda Molyneaux, Dennis K. Yue, Janusz M. Gebicki, David Sullivan, Jane Overland, Richard Donnelly, Jeff R. Flack, Stephen M. Twigg and Ip Tim Lau and has published in prestigious journals such as Diabetes Care, The American Journal of Cardiology and Biochemical Pharmacology.

In The Last Decade

K. Willey

10 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Willey Australia 8 146 122 75 51 47 10 331
T William-Olsson Sweden 7 146 1.0× 110 0.9× 161 2.1× 63 1.2× 24 0.5× 7 386
Abhijit A. Ghadge India 9 112 0.8× 143 1.2× 31 0.4× 93 1.8× 16 0.3× 15 422
Ana M. Puyó Argentina 13 164 1.1× 107 0.9× 49 0.7× 92 1.8× 21 0.4× 42 417
Leszek Szadujkis‐Szadurski Poland 9 71 0.5× 103 0.8× 27 0.4× 84 1.6× 24 0.5× 29 354
Mohammad Irshad Reza India 12 131 0.9× 87 0.7× 33 0.4× 105 2.1× 15 0.3× 30 394
Claudemir Gregório Mendes Brazil 10 66 0.5× 126 1.0× 20 0.3× 69 1.4× 32 0.7× 25 343
Gina Varricchio Italy 11 177 1.2× 155 1.3× 36 0.5× 82 1.6× 94 2.0× 16 611
S. Madani Algeria 10 122 0.8× 108 0.9× 18 0.2× 82 1.6× 41 0.9× 12 463
Masayuki Inouye Japan 13 74 0.5× 87 0.7× 25 0.3× 56 1.1× 30 0.6× 18 427
V. Balbi Italy 8 160 1.1× 285 2.3× 39 0.5× 111 2.2× 153 3.3× 11 720

Countries citing papers authored by K. Willey

Since Specialization
Citations

This map shows the geographic impact of K. Willey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Willey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Willey more than expected).

Fields of papers citing papers by K. Willey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Willey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Willey. The network helps show where K. Willey may publish in the future.

Co-authorship network of co-authors of K. Willey

This figure shows the co-authorship network connecting the top 25 collaborators of K. Willey. A scholar is included among the top collaborators of K. Willey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Willey. K. Willey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Willey, K. & Maria A. Fiatarone Singh. (2003). Battling Insulin Resistance in Elderly Obese People With Type 2 Diabetes. Diabetes Care. 26(5). 1580–1588. 120 indexed citations
2.
Willey, K.. (1999). An elusive role for glycosylation in the structure and function of reproductive hormones. Human Reproduction Update. 5(4). 330–355. 26 indexed citations
3.
Lau, Ip Tim, K. Willey, Lynda Molyneaux, et al.. (1998). Does Insulin Therapy Have a Hypertensive Effect in Type 2 Diabetes?. Journal of Cardiovascular Pharmacology. 32(1). 39–41. 10 indexed citations
4.
Molyneaux, Lynda, K. Willey, & Dennis K. Yue. (1996). Indapamide Is as Effective as Captopril in the Control of Microalbuminuria in Diabetes. Journal of Cardiovascular Pharmacology. 27(3). 424–427. 16 indexed citations
5.
Donnelly, Richard, Lynda Molyneaux, K. Willey, & Dennis K. Yue. (1996). Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria. The American Journal of Cardiology. 77(6). B26–B30. 13 indexed citations
6.
Willey, K., Lynda Molyneaux, & Dennis K. Yue. (1994). Obese Patients with Type 2 Diabetes Poorly Controlled by Insulin and Metformin: Effects of Adjunctive Dexfenfluramine Therapy on Glycaemic Control. Diabetic Medicine. 11(7). 701–704. 24 indexed citations
7.
Flack, Jeff R., Lynda Molyneaux, K. Willey, & Dennis K. Yue. (1993). Regression of Microalbuminuria. Journal of Cardiovascular Pharmacology. 22. 78–78. 6 indexed citations
8.
Willey, K., Stephen M. Twigg, Maria Constantino, Dennis K. Yue, & John R. Turtle. (1993). Home blood glucose monitoring: How often?. Practical Diabetes International. 10(1). 22–25. 4 indexed citations
9.
Gebicki, Janusz M., et al.. (1992). Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochemical Pharmacology. 43(5). 995–1000. 75 indexed citations
10.
Willey, K., Lynda Molyneaux, Jane Overland, & Dennis K. Yue. (1992). The Effects of Dexfenfluramine on Blood Glucose Control in Patients with Type 2 Diabetes. Diabetic Medicine. 9(4). 341–343. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026